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Abstract
Background
Rapid diagnostic test (RDT) kits have been useful tools to screen for the presence of infec-
tion with malaria parasites. Despite the improvement, false results from RDTs present a
greater challenge. The need for quality test kits is desirable. We evaluated the diagnostic
accuracy of three malaria RDTs.
Method
The team consented and enrolled 754 participants from the two major public hospitals in
Kintampo districts of Ghana from June 2014 to August 2014. Venous blood samples were
obtained by trained personnel and samples were screened for malaria using CareStart and
SD Bioline HRP2 and HRP2 with pLDH based RDTs with blood slides for malaria micros-
copy as “gold standard”. Geometric mean parasite densities were estimated and parasite
densities were used to estimate the quantitative limits of the RDTs. The sensitivities, speci-
ficities and other performance criteria were calculated using statistical analytical software.
Result
The median age of participants was 21 (range 5–31) years. There were 28.6% (215/752)
were males and 71.4% (537/752) were females. Comparing with microscopy, the sensitivity,
specificity, positive predictive value, negative predictive value and the ROC were for CareS-
tart (HRP2), 98.2%, 66.5%, 82.6%, 95.6%, 0.82; for CareStart (HRP2/pLDH) 98.2%,
66.5%, 82.6%, 95.6%, 0.82 and for SD-Bioline (HRP2/pLDH) RDTs 98.2%, 69.2%, 84.2%,
96.0%, 0.84 respectively. The performance for all the kits were acceptable at a cut-off of 25
or more parasites/μl of blood.
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Conclusions
The diagnostic performance of the three malaria RDTs was acceptable, according to the
World Health Organisation criteria, to detect densities25 parasite/μl of blood. The RDTs
with HRP2/pLDH targets were comparable to those with only HRP2 and could successfully
substitute current and commonly used HRP2-based RDTs.
Background
Malaria parasite infection contributes greatly to morbidity and mortality in the developing
part of the world [1]. A larger proportion of the cases of malaria infection in Africa is attribut-
able to Plasmodium falciparum infection [2, 3]. Plasmodium falciparum (Pf) is responsible for
the high cause of deaths in children who are 5 years of age or less [4, 5]. Malaria is typically
diagnosed using light microscopy and this is accepted and regarded as the reference method
[6–8]. A number of rapid diagnostic tests (RDTs) kits have also been developed for use in both
non-endemic and endemic countries as part of malaria management and control programs [9]
and the quality of kits produced has improved over the years [1, 10].
Artemisinin-based Combination Therapy (ACT) use, as recommended by the World
Health Organisation (WHO), is restricted to patients with confirmed malaria parasite infec-
tions [11, 12]. With the challenge of availability of skill and logistics to microscopy in several
facilities in sub-Saharan Africa, RDTs are used for confirmation of malaria parasite infection
during diagnosis before treatment with antimalarials. In the absence of RDTs, most febrile ill-
nesses are treated presumptively [13] as malaria without laboratory confirmation and espe-
cially where the skill for microscopy does not exist. The effects of presumptive diagnosis and
treatment such as increased cost of treating malaria, missing other diagnosis, extensive overuse
of anti-malarial have extensively been published [14]. It is therefore expedient to make avail-
able an economic and time efficient method that is reliable but requires less skills to perform.
This gap is filled by introduction of quality RDTs [10, 15, 16]. Conversely, RDTs could give
false results [8, 17] which present another challenge. The reason is that initiation of treatment
might be delayed and this may possibly lead to deterioration in the condition of victims with
malaria. The quality and performance of RDTs is not in doubt [18]. RDTs have improved
from the start of their production and the product testing programme by WHO and the Global
Health in 2017 [1, 10, 18]. In a study carried out in Ghana, the performance of an Histidine-
rich protein 2 (HRP2)-based RDTs recorded a sensitivity and specificity of 100% and 73%
respectively [7]. In Tanzania and among children (2 months to 13 years), testing of HRP2
branded RDT revealed a sensitivity of 98.2% [19]. Of great concerns were the false-negative
results reported in other studies. In one, RDTs missed 8.8% (3/34) of malaria parasite positive
cases in which parasitaemia were above determined detectable thresholds of the RDTs [20].
Histidine-rich protein 2 (HRP2) target is used for most malaria RDTs and the test is based on
detection of the protein expressed by the Plasmodium falciparum hrp2 gene [8]. Spontaneous
hrp2 deletions is reported to occur as was seen by Koita et al, 2012 and that P. falciparum para-
sites with such deletions cannot be detectable [8, 17] using RDT targeting HRP2 protein.
RDTs based solely on HRP2 would give a false-negative results when used to screen infected
persons with HRP2 deleted strains of malaria parasites. With the quest to improve malaria
diagnostic testing and to overcome some of the anticipated challenges infection with parasites
with hrp2-deleted gene pose, combination of multiple protein targets is suggested in the devel-
opment of malaria RDTs. One of such parasite protein is the parasite Lactate Dehydrogenase
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(pLDH). It is believed that addition of pLDH to HRP2 in RDTs can improve their perfor-
mance by identifying malaria parasites with hrp2-gene deletion [17, 18], help to differentiate
current from convalescent infections and even to possibly identify infections that persist as a
result of treatment failure [18, 21, 22]. We evaluated the diagnostic accuracy of CareStart
(HRP2), CareStart (HRP2-pLDH) and SD-Bioline (HRP2/pLDH) using light microscopy as
“gold standard” in middle Ghana, Africa among hospital attendant participants.
Methods
Ethical statement
The team presented all information including the objectives and procedures of the study to
every participant. The team sought and obtained written informed consent from all adult par-
ticipants and from the parents of all minors to voluntarily participate in the study. Care-takers
were invited to give their written informed consent on behalf of participating minors. Children
aged 10 to 17 years were invited to give their written informed assent for consenting in addi-
tion to their parental consent. The Kintampo Health Research Centre Institutional Ethics
Committee (KHRC-IEC) (FWA No. 00011103) gave ethical approval of the protocol before
the study commenced.
Study design, site, population and participant selection
The team adopted a cross-sectional study design. The study was conducted in Kintampo
North Municipal and Kintampo South District all in the Brong Ahafo Region of Ghana, West
Africa. The study area is estimated to cover about 7162 sqkm with a resident population of
approximately 140,000 [23]. The location of the study area has been well described by Owusu-
Agyei et al 2009 [23, 24]. Prevalence of malaria parasitaemia (symptomatic/asymptomatic) in
the area was about 50% among children below 10 years old. The area had entomological inocu-
lation rate (EIR) of 269 infective bites per person per year [24–26] and malaria transmission is
perennial. There are three (3) hospitals, more than twelve (12) clinics [27] and 30 community-
based health planning services (CHPS) compounds [28]. Participants were recruited from the
two major public hospitals that serve as patient referral points in the study area. In these facili-
ties, routine malaria diagnosis is made either by malaria microscopy or using Rapid Diagnostic
Test (RDT) kits. In Community based health facilities (CHPS compounds), RDTs are mainly
used to diagnose malaria parasite infection.
Sample size determination
A minimum sample size of 350 was determined, based on our sample size calculation. We
assumed 0.98 expected Area under ROC curve compared to 0.95 of a Null hypothesis value
[7], 1:2 ratio of sample sizes in negative/positive groups and 5% confidence limits. At 90%
power, a minimum of 233 malaria-positive and 117 malaria-negative participants were consid-
ered to be enough to evaluate the accuracy of the malaria RDTs kits in this study (MedCalc
version 12.5 software, Mariakerke, Belgium).
Study procedure
Personnel from Kintampo Health Research Centre (KHRC) and the two major public hospi-
tals carried out the study activities to recruit the number of participants needed from the health
facilities from June 2014 to August 2014. Patients that had requests on their forms for malaria
tests to be done in the hospitals’ laboratories were contacted to seek their voluntary written
informed consent to be recruited to participate in the study. The study required participants to
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donate 2mls of venous blood samples for evaluation of the test kits. The study information,
activities and procedures were explained in turn to each participant; allowing each of them time
to decide whether to participate or not. The study team obtained written informed consent
from each participant enrolled in the study period from the two major public hospitals. Demo-
graphic data such as age and sex were collected. The blood samples were collected into EDTA
test tubes by trained study laboratory personnel and transported to the KHRC laboratory for
analysis according to the Standard Operating Procedures for sample collection, transport and
analysis. Ten percent (10%) of the samples were retested as quality assurance measure for the
RDT methods. This was done by selecting every 10th sample for RDT retesting.
Laboratory processes
Blood samples taken from the two major health facilities and received in KHRC laboratory
were used to screen for malaria parasites using the three malaria RDTs (CareStart Malaria
(HRP2), CareStart Malaria (HRP2/pLDH), SD Bioline Malaria (HRP2/pLDH)) and also using
routine microscopy as the “gold standard”.
Blood slide reading for malaria parasite. Thick and thin blood slides films were prepared
from each sample received in the KHRC laboratory and used for malaria parasite identification
as described previously [24, 29]. In brief, a measured volume of 6 μl of blood was used for the
thick film on a predefined template of 12 mm and 2 μl for the thin film. For 10 minutes, the
slides were stained with 10% (1:9 ml) of fresh working solution of Giemsa stains prepared
freshly prior to staining the thin and thick blood smears after fixing the thin smear with abso-
lute methanol [24, 29]. Two competent (grading based on National Institute for Communica-
ble Disease Assessment, South Africa), malaria microscopists independently read the blood
smears [24, 29]. A third reader was used whenever there was discordance between the first two
microscopists. Final results were produced from two results that agreed from two of the three
independent microscopists.
Malaria Rapid Diagnostic Test (RDT) Kits. Participants’ samples were also screened for
malaria parasites using 5 μl with each of the RDTs from CareStart Malaria (HRP2), CareStart
Malaria (HRP2/pLDH) (both manufactured by Access Bio Inc., New Jersey USA) and SD Bio-
line Malaria Antigen Pf (HRP2/pLDH) (Standard Diagnostics, Hagal-Dong, Korea). Each of
the CareStart malaria RDTs (both HRP2 and HRP2/pLDH) had only two bands consisting of a
control (“C”) and test (“T”) lines each. With the CareStart RDTs, a test is positive for malaria
parasite when there is a reaction in the control and test lines. The control band must at all
times be positive before a test could be classified as valid (Manufacturer’s instructions). For SD
Bioline Malaria Antigen Pf (HRP2/pLDH), there were three bands representing a control line
(“C”) and two separate test lines (labelled as “T1” and “T2”). The antigens that were targeted
were Pf-HRP2 (T1) and Plasmodium vivax (Pv)-, Plasmodium ovale (Po)-, Plasmodium malar-
iae (Pm)-or Pf-pLDH (T2) put on the same strip [22]. For the interpretation of the SD Bioline
test kit as appeared in the packaging insert, two colour band, “C” and “T1” indicated Pf posi-
tive while “C” and “T2” indicated positive test for other Plasmodium species (Pv., Pm, Po or
Pf). With three colour bands, positive “C”, “T2” and “T1” lines were interpreted as mixed
infection of Pf and any of the other Plasmodium species. There was no case where “T1” was
negative and “T2” was positive. The study strictly adhered to the manufacturers’ instructions
to obtain good results from the RDTs. Results from two independent observers that were con-
cordant were used as the final results for the RDT tests. One general challenge that was identi-
fied with both RDTs was the fact that extra caution needed to be taken to be able to fill the
volume of blood needed for testing to the mark (5 μl). Improving in the process of filling the
capillary tubes would improve in the test performance time.
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Measurement of blood cell counts. Full Blood Count of haematological parameters was
determined with ABX Micros 60 analyzers (Horiba-ABX, Montpellier, France). The validated
instrument was used to obtain the counts of blood cells of interest to estimate the malaria para-
site densities [24, 29–31] necessary for the evaluation studies.
Data management and analysis
Supervisors checked for data completeness and consistency. Data were then double-entered
using Microsoft Access software 2010. All queries were resolved after data entry. Stata Software
version 13 (Stata Corporation, TX USA) and MedCalc software version 12.5 (Mariakerke, Bel-
gium) were used on the cleaned data for analysis. The calculated sensitivity (SE), specificity
(SP), negative and positive predictive values (PPV and NPV) and the Area under the Receiver
Operator Characteristics (ROC) curve using malaria microscopy results as “gold standard”
was used to estimate the diagnostic performance of the malaria RDTs. In estimating SE, we cal-
culated the proportion of positive test results identified by the test kit compared to the positives
given by the “gold standard”. With SP of the RDT, the proportion of negative test results was
compared to the true negatives given by the “gold standard” (microscopy). The PPVs and the
NPVs were calculated as described by Endeshaw et al, 2012 [32]. All reported parameters in
the study were considered significant with 95% Confidence Intervals.
The formulae below were employed in our calculations.
Sensitivity ¼
Number of true positives ðTPÞusing the reference method
ðNumber of true positives ðTPÞÞ þ ðNumber of false negatives ðFNÞÞ
Specificity ¼
Number of true negatives ðTNÞ using the reference method
ðNumber of true negatives ðTNÞÞ þ ðNumber of false positives ðFPÞÞ
False Positive Rate FPRð Þ ¼
False PositiveðFPÞ
ðFalse Positive ðFPÞÞ þ ðTrue Negative ðTNÞÞ
Quality assurance measures adopted
All personnel that were involved in the study and testing processes before the start of the study
were trained on the protocol and procedures. According to, and using the manufacturers’
instructions, the training included handling the RDTs, picking blood with the pipette for test-
ing on the RDTs, use of the buffer for RDT and the reading and interpretation of test from the
RDTs. The methods for preparing the blood films (thin and thick), staining and species identi-
fication were also included in the training schedule [24, 29]. The team also included training
personnel to uniformly classify test outcomes as ‘‘positive” or ‘‘negative” as described in the
manufacturers’ instructions for the RDTs. The team that performed the tests were blinded to
the processes and results of each method of other tests. Quality controls for blood count
parameters were performed with commercially available controls from Horiba-ABX, Montpel-
lier, France but already prepared “Positive” and “Negative” microscope slides were used to
quality control the giemsa working stains [30, 31] for each day’s work. The malaria RDT kits
were controlled internally with known positive and negative samples from previous days’
work. The flow chart shown in Fig 1 gives the number of recruited participants’ and samples
analysed.
Diagnostic performance of three malaria RDTs
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Fig 1. Flow chart for participant recruitment and data analysis.
https://doi.org/10.1371/journal.pone.0203524.g001
Diagnostic performance of three malaria RDTs
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Results
Study population characteristics
A total of 453 out of 754 samples from participants recruited from the two major public hospi-
tals in the Kintampo North and South districts were used to evaluate the rapid diagnostic test
kits. Of these, 28.7% (130/453) were males and 71.3% (323/453) were females. The demo-
graphic profile of the participants are shown in Table 1. The median age of participants was 21
(5–31) years. The prevalence of malaria based on microscopy in the number of participants
recruited into the study was 39.1% (281/754) (Fig 1). The rank sum test for malaria parasite
densities compared among males (n = 216) and females (n = 538) participants recruited for
the study were similar (p = 0.218).
Comparing the diagnostic accuracy of malaria RDTs and microscopy
(“gold standard”)
The parasite density for P. falciparum ranged between 25 and 903120 parasites/μl of blood
(IQR: 589–88580) with median density of 9695 parasite/μl.
CareStart malaria (HRP2) RDT and Malaria microscopy: The SE, SP, PPV and NPV
with their confidence limits, of CareStart malaria (HRP2) RDT method compared to the “gold
standard” were 98.2% (95% CI: 95.9, 99.4), 66.3% (95% CI: 58.7, 73.3), 82.6% (95% CI: 78.1,
86.5) and 95.8% (95% CI: 90.5, 98.6) respectively (Table 2). The ROC was 0.82 (95% CI: 0.79,
0.86) (Table 2). The kit reported a false positive rate (FPR) of 34% for true disease and a false
negative rate of 1.8%.
CareStart malaria (HRP2/pLDH) RDT and Malaria microscopy. The SE, SP, PPV and
NPV with their confidence limits, of CareStart malaria (HRP2/pLDH) RDT method compared
to the “gold standard” were 98.2% (95% CI: 95.9, 99.4), 66.3% (95% CI: 58.7, 73.3), 82.6% (95%
CI: 78.1, 86.5) and 95.8% (95% CI: 90.5, 98.6) respectively (Table 2). The ROC was 0.82 (95%
CI: 0.79, 0.86) (Table 2). The kit reported a false positive rate (FPR) of 34% for true disease and
a false negative rate of 1.8%.
SD Bioline malaria (HRP2/pLDH) RDT and Malaria microscopy. The SE, SP, PPV and
NPV with their confidence limits, of SD Bioline malaria (HRP2/pLDH) RDT method com-
pared to the “gold standard” were 98.2% (95% CI: 95.9, 99.4), 69.2% (95% CI: 61.7, 76.0),
83.9% (95% CI: 79.5, 87.7) and 90.4% (95% CI: 90.8, 98.7) (Table 2). The ROC was 0.84 (95%
CI: 0.80, 0.87) respectively (Table 2). The kit reported a false positive rate (FPR) of 31% for
true disease and a false negative rate of 1.8%.
Table 1. Demographic profile of the population involved in this study.
Sex n (%)
Males 216 (28.7)
Females 538 (71.3)
Age Group (years): n (%)
<11 183 (40.4%)
11–20 68 (15.0%)
21–30 113 (24.9%)
31–40 49 (10.8%)
>40 40 (8.8%)
Any antimalaria in the last week n (%)
Yes 105 (14.1)
No 642 (85.9)
https://doi.org/10.1371/journal.pone.0203524.t001
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In 5 samples, all three RDTs read negative compared to the “gold standard”. The parasite
densities in these 5 samples were 36, 44, 36, 73 and 81 parasites/μl of blood. However, the
RDTs could identify positive cases compared to microscopy for 19 other samples with parasite
densities from 25 parasites/μl of blood to 96 parasites/μl of blood. This is suggestive of some-
thing else other than the low parasite density which might have led to the 5 negative results in
Table 2. Again, none of the 5 participants claimed they had not taken antimalarial in the last
week prior to our visit.
Performance of malaria RDTs at parasite density cut-off points. Considering the per-
formance of the kit at a cut-off criteria of 25, 50, 100, 200, 1000, 5000, 10000, 50000 and
1000000 parasites/μl of blood, a ROC of 0.97 was obtained for all the three malaria RDTs as
presented in Fig 2. The sensitivities of the RDT kits were high at malaria parasite densities
from 25 parasite/μl to 200 parasites/μl of blood (S1–S3 Tables). The agreement between CareS-
tart Malaria (HRP2) and CareStart Malaria (HRP2/pLDH) was high (k = 100%) and either
CareStart Malaria (HRP2) or CareStart Malaria (HRP2/pLDH) compared with SD Bioline
Malaria Antigen P.f (HRP2/pLDH) also had high agreement (k = 98.7%) each.
Discussion
Rapid Diagnostic Tests (RDTs) of different makes have played significant roles in the manage-
ment of malaria. As new formulations emerge, they need to be assessed to determine their
roles in malaria diagnosis. The diagnostic performances of CareStart Malaria (HRP2) RDTs
compared to malaria microscopy, of CareStart Malaria (HRP2/pLDH) RDTs, and of SD Bio-
line Malaria Antigen Pf (HRP2/pLDH) RDTs evaluated in this study were acceptable with sen-
sitivities higher than 98% and varied specificity from 66.3% to 69.2% (Table 2). The accuracy
recorded in this study is comparable to what have been documented by other studies [7, 22].
The diagnosis, treatment and overall management of malaria adopt several guidelines using
clinical judgement together with the parasitological detection of malaria parasites based on
available accurate, validated and accepted standards for testing. Malaria which is known to be
a leading cause of morbidity and mortality in the developing world [1] is preferably diagnosed
using malaria microscopy as the “gold standard”. The quality of equipment, quality assurance
measures, time required and level of expertise required to effectively produce reliable results
using microscopy [29] has always been a challenge in resource deprived settings and largely in
the developing world. It has been the expectations that malaria RDTs could fill the gap in those
deprived settings to enable rapid screening and aid in malaria diagnosis. It is interesting to
note that performance of some of the malaria RDTs including those evaluated in this study are
comparable to using the microscope [7] despite their limitations in sensitivity and specificity
Table 2. Diagnostic performance of the CareStart malaria (HRP2 and HRP2/pLDH) and SD bioline malaria (HRP2/pLDH) RDT kit to microscopy.
Gold standard Positive
(N = 281)
Gold standard Negative
(N = 172)
Sensitivity
% (95% CI)
Specificity
% (95% CI)
PPV
% (95% CI)
NPV
% (95% CI)
AUC
(95% CI)
RDT Positive
(n)
RDT
Negative
(n)
RDT Positive
(n)
RDT
Negative
(n)
Type of Malaria RDT
CareStart (HRP2) 276 5 58 114 98.2 (95.9,
99.4)
66.3 (58.7,
73.3)
82.6 (78.1,
86.5)
95.8 (90.5,
98.6)
0.82 (0.79,
0.86)
CareStart (HRP2/
pLDH)
276 5 58 114 98.2 (95.9,
99.4)
66.3 (58.7,
73.3)
82.6 (78.1,
86.5)
95.8 (90.5,
98.6)
0.82 (0.79,
0.86)
SD Bioline (HRP2/
pLDH)
276 5 53 119 98.2 (95.9,
99.4)
69.2 (61.7,
76.0)
83.9 (79.5,
87.7)
96.0 (90.8,
98.7)
0.84 (0.80,
0.87)
https://doi.org/10.1371/journal.pone.0203524.t002
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[8, 22, 32]. One of such limitations is that some of the RDTs just as those evaluated in this
study could have false positive rates >10% [1, 18, 21] and need to be looked at since such kits
have increased possibility of giving false positive result.
The technique employed in developing these RDTs is based on detecting the HRP2 or
HRP2 with pLDH proteins of malaria parasites if present. Recent reports of human infections
with malaria parasites with hrp2 gene deletion have brought up the discussion of “false negative
reporting” when RDTs solely developed with HRP2 based proteins are used for testing [8, 17].
It is worth mentioning that the performance of the three brands of malaria RDTs evaluated in
this study had high diagnostic performance based on sensitivity according to acceptable stan-
dards of WHO (Fig 2 and Table 2) just as those solely developed with HRP2 targets. This sug-
gests that RDTs developed to target both HRP2 and pLDH antigens simultaneously perform
as well as those manufactured to detect only the HRP2 antigens of the malaria parasites. The
RDTs could be used for screening and diagnosis when there is the fear of reduced reliability of
HRP2-detecting RDTs because of hrp2 gene deletion in some strains of malaria parasites [33].
This is on the assumption that parasites with hrp2 gene deletion are expected to produce pLDH
which would be detected when the parasite is present considering the time of sample analysis
[21, 22]. However, the possibility of the RDTs being able to detect parasites with hrp2 gene
Fig 2. ROC curve of the three malaria RDT performance with plotted points of parasite densities at selected cut-off points.
https://doi.org/10.1371/journal.pone.0203524.g002
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deletion needs to be explored. This is because, the RDTs could not identify the infection that
was identified by microscopy in 5 samples. In these samples it is unlikely that the RDTs failed
to identify parasites because they had low parasite density since other samples had comparable
parasite densities but were correctly identified by the RDTs. A thorough review of HRP2-based
RDTs is required given the reports of hrp2 gene deletion infections in Mali [8] and potentially
in Ghana as suggested by Amoah et al, 2016 [17].
The three RDTs evaluated in this study had acceptable performance in samples that had
parasite densities from 25 to 200 parasites/μl of blood. It is assuring to note that the kits with
targets to pLDH detecting antigens in addition to HRP2 performed well compared with only
HRP2 antigen detecting kit at low parasite densities. The RDT kits particularly with pLDH
detecting antigens can therefore be considered for use to screen and detect infections with
Plasmodium falciparum. The kits therefore have the potential to be used for effective malaria
diagnosis that will prevent over prescription of antimalarials.
These malaria RDTs which are all packaged ready for use require less skills and complex
equipment to perform. The malaria RDTs evaluated in this study like all others used approxi-
mately 15 minutes to give reliable results without any equipment that require electricity. This
will effectively improve early detection and diagnosis of malaria parasite infection for prompt
treatment especially in endemic region.
Limitations of the study
The study was carried out in three months (June-August), corresponding to the rainy season
where malaria transmission is very high. However, malaria transmission and infection is
perennial with peaks and troughs in the study area and the range of parasite densities recorded
in this study cut across low to high densities. It is assumed that results obtained from the rainy
season would apply in the dry season as well, which may not be true. However, the sample size
considered adequate number of positive and negative cases in their correct ratios and that in
our view would not be significantly affected by season in validating the results and perfor-
mance of the kits.
Conclusion
The diagnostic performance of the HRP2 and HRP2 with pLDH based RDTs assessed in this
study was acceptable and could detect parasitaemia as low as 25 parasite/μl of blood. The
HRP2 RDTs combined with pLDH targets be considered for malaria control programmes.
There is however a decrease in specificity which could result from the persistence of HRP2
proteins even weeks after effective treatment of malaria.
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